PC-TRiADD’s comprehensive Pharmacology and Drug Design unit helps clients to identify novel drug candidates using methods of computational drug design and cheminformatics, followed by hit-to-lead optimization combined with comprehensive experimental evaluation of pharmacological activity. Our expert team is experienced in both computational and experimental aspects of conventional drug discovery and can seamlessly integrate their services with PC-TRiADD’s other units to provide all the necessary components of focused translational research.